Impact of South American heroin on the US heroin market 1993-2004

International Journal of Drug Policy

Volumn 20, Issue 5, 2009, Pages 392-401

  Ciccarone, Daniel ^a   Unick, George J ^b   Kraus, Allison ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heroin; Heroin distribution; Heroin economics; Heroin supply; Illicit drug history; Medical consequences of heroin use

Indexed keywords

DIAMORPHINE;

ARTICLE; COLOMBIA; CONTROLLED STUDY; COST; DRUG TRAFFIC; HEROIN DEPENDENCE; MARKETING; PREDICTION; PRIORITY JOURNAL; SOUTH AMERICA; TREND STUDY; UNITED STATES;

COMMERCE; DRUG AND NARCOTIC CONTROL; DRUG CONTAMINATION; HEROIN; HUMANS; MODELS, STATISTICAL; SOUTH AMERICA; UNITED STATES;

EID: 67651111684     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.12.001     Document Type: Article

References (76)

1. Afifi A.A., Kotlerman J.B., Ettner S.L., and Cowan M. Methods for improving regression analysis for skewed continuous or counted responses. Annual Review of Public Health 28 (2007) 95-111
2. Bardenheier B., Prevots D.R., Khetsuriani N., and Wharton M. Tetanus surveillance-United States 1995-1997. MMWR CDC Surveillance Summary 47 2 (1998) 1-13
3. Binswanger I.A., Kral A.H., Bluthenthal R.N., Rybold D.J., and Edlin B.R. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases 30 3 (2000) 579-581
4. Bretteville-Jensen A.L. Gender, heroin consumption and economic behaviour. Health Economics 8 5 (1999) 379-389
5. Bretteville-Jensen A.L., and Biørn E. Heroin consumption, prices and addiction: Evidence from self-reported panel data. Scandinavian Journal of Economics 105 4 (2003) 661-679
6. Broz D., and Ouellet L.J. Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence 94 1-3 (2008) 221-233
7. Bryant W.K., Galea S., Tracy M., Markham Piper T., Tardiff K.J., and Vlahov D. Overdose deaths attributed to methadone and heroin in New York City 1990-1998. Addiction 99 7 (2004) 846-854
8. Bucardo J., Brouwer K.C., Magis-Rodriguez C., Ramos R., Fraga M., Perez S.G., et al. Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections. Drug and Alcohol Dependence 79 3 (2005) 281-293
9. Caulkins J., and Reuter P. The meaning and utility of drug prices. Addiction 91 9 (1996) 1261-1264
10. Caulkins J.P. Drug prices and emergency department mentions for cocaine and heroin. American Journal of Public Health 91 9 (2001) 1446-1448
11. Ciccarone D. The political economy of heroin: Regional markets, practices and consequences. International Journal of Drug Policy 17 5 (2005) 289-290
12. Ciccarone D. Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market. International Journal of Drug Policy (2008) doi:10.1016/j.drugpo.2008.08.003
13. Ciccarone D., Bamberger J., Kral A., Edlin B., Hobart C., Moon A., et al. Soft tissue infections among injection drug users-San Francisco, California 1996-2000. MMWR Morbidity and Mortality Weekly Report 50 19 (2001) 381-384
14. Ciccarone D., and Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use and Misuse 38 14 (2003) 2049-2063
15. DEA Congressional Testimony by Thomas A. Constantine, Administrator, Drug Enforcement Administration. (1996). Before the: House Subcommittee on the Western Hemisphere & House International Relations Committee. Regarding: Drug Control in the Western Hemisphere. June 6, 1996.
16. Cooper H.L., Brady J.E., Ciccarone D., Tempalski B., Gostnell K., and Friedman S.R. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clinical Infectious Diseases 45 9 (2007) 1200-1203
17. Cropper, C.M. (1997). 10 heroin deaths in Texas reflect rising use by young. New York Times, November 23, p. 30.
18. Darke S., Hall W., Weatherburn D., and Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug and Alcohol Dependence 54 2 (1999) 155-161
19. Darke S., Topp I., Kaye H., and Hall W. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 97 2 (2002) 179-186
20. Dave D. The effects of cocaine and heroin price on drug-related emergency department visits. Journal of Health Economics 25 2 (2006) 311-333
21. Degenhardt L., Reuter P., Collins L., and Hall W. Evaluating explanations of the Australian 'heroin shortage'. Addiction 100 4 (2005) 459-469
22. Efron B., and Tibshirani R. An introduction to the bootstrap (1993), Chapman & Hall, New York
23. Fernandez W., Hackman H., McKeown L., Anderson T., and Hume B. Trends in opioid-related fatal overdoses in Massachusetts, 1990-2003. Journal of Substance Abuse Treatment 31 2 (2006) 151-156
24. Frank B. An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine 67 5-6 (2000) 340-346
25. Gibson A., Degenhardt L., Day C., and McKetin R. Recent trends in heroin supply to markets in Australia, the United States and Western Europe. International Journal of Drug Policy 16 5 (2005) 293-299
26. Gray M. Texas heroin massacre. Rolling Stone 813 (1999) 32-36
27. Grossman M., and Chaloupka F.J. The demand for cocaine by young adults: A rational addiction approach. Journal of Health Economics 17 4 (1998) 427-474
28. Harris H.W., and Young D.M. Care of injection drug users with soft tissue infections in San Francisco California. Archives of Surgery 137 11 (2002) 1217-1222
29. Horowitz J.L. Should the DEA's Stride data be used for economic analyses of markets for illegal drugs?. Journal of the American Statistical Association 96 456 (2001) 1254-1271
30. Hughes P.H., and Rieche O. Heroin epidemics revisited. Epidemiologic Reviews 17 1 (1995) 66-73
31. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the future national survey results on drug use, 1975-2005. Vol. II: College students and adults ages 19-45. (NIH Publication No. 06-5884) (2006), National Institute on Drug Abuse, Bethesda, MD
32. Kimura A.C., Higa J.I., Levin R.M., Simpson G., Vargas Y., and Vugia D.J. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clinical Infectious Diseases 38 9 (2004) e87-91
33. Landen M.G., Castle S., Nolte K.B., Gonzales M., Escobedo L.G., Chatterjee B.F., et al. Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in New Mexico. American Journal of Epidemiology 157 3 (2003) 273-278
34. Maher L., Li J., Jalaludin B., Wand H., Jayasuriya R., Dixon D., et al. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales Australia. Drug and Alcohol Dependence 89 2-3 (2007) 244-250
35. Maxwell, J. (2007). 'Cheese' heroin: Status as of June 2, 2007. Retrieved August 4, 2007, from http://www.utexas.edu/research/cswr/gcattc/documents/cheeseheroin6-2-07_ 000.pdf.
36. Moore T.J., Caulkins J.P., Ritter A., Dietze P., Monagle S., and Pruden J. Monograph No. 09: Heroin markets in Australia: Current understandings and future possibilities (2005), Turning Point Alcohol and Drug Centre, Fitzroy
37. Murphy E.L., DeVita D., Liu H., Vittinghoff E., Leung P., Ciccarone D.H., et al. Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clinical Infectious Diseases 33 1 (2001) 35-40
38. Nixon, R. (June 17, 1971). Remarks about an intensified program for drug abuse prevention and control. Spoken to the White House Briefing Room, The American Presidency Project: http://www.presidency.ucsb.edu.
39. Office of National Drug Control Policy. The price and purity of illicit drugs: 1981 through the second quarter of 2003 (2004), Executive Office of the President, Office of National Drug Control Policy, Washington, DC
40. Office of National Drug Control Policy (2007). "Cheese" heroin. Retrieved July, 2007, from http://www.whitehousedrugpolicy.gov/publications/cheese/index.html.
41. Oxman G., Kowalski S., Drapela L., Gray E.S., and Fafara S. Heroin overdose deaths-Multnomah County, Oregon 1993-1999. MMWR Morbidity and Mortality Weekly Report 49 28 (2000) 633-636
42. Passaro D.J., Werner S.B., McGee J., Mac Kenzie W.R., and Vugia D.J. Wound botulism associated with black tar heroin among injecting drug users. Journal of The American Medical Association 279 11 (1998) 859-863
43. Ruttenber A.J., and Luke J.L. Heroin-related deaths: New epidemiologic insights. Science 226 4670 (1984) 14-20
44. Saffer H., and Chaloupka F. The demand for illicit drugs. Economic Inquiry 37 3 (1999) 401-411
45. Solet D., Hagan H., Nakagawara J., Plough A., and Ball J. Unintentional opiate overdose deaths-King County, Washington 1990-1999. MMWR Morbidity and Mortality Weekly Report 49 28 (2000) 636-640
46. StataCorp. Stata statistical software: Release 10 (2007), StataCorp LP, College Station, Texas
47. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. Emergency department trends from The Drug Abuse Warning Network, preliminary estimates January-June 2001 with revised estimates 1994-2000 (2002), Department of Health and Human Services, Rockville, MD
48. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. Emergency department trends from The Drug Abuse Warning Network, final estimates 1995-2002 (2003), Department of Health and Human Services, Rockville, MD
49. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. Mortality data from The Drug Abuse Warning Network, 2003 (2005), Department of Health and Human Services, Rockville, MD
50. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. The DASIS report: Heroin-changes in how it is used: 1995-2005 (April 26, 2007), Department of Health and Human Services, Rockville, MD
51. Substance Abuse and Mental Health Services Administration: Office of Applied Studies. The DASIS report: Heroin-changes in how it is used (July 20, 2001), Department of Health and Human Services, Rockville, MD
52. Thoumi F.E. Illegal drugs, economy, and society in the Andes (2003), Woodrow Wilson Center Press, Washington, DC
53. Topp L., Kaye S., Bruno R., Longo M.C., Williams P., O'Reilly B., et al. Australian drug trends 2001: Findings from the Illicit Drug Reporting System (IDRS) (2002), National Drug and Alcohol Research Centre, Sydney
54. United Nations Office on Drugs and Crime. 2005 world drug report (2005), United Nations Office on Drugs and Crime, Vienna
55. United Nations Office on Drugs and Crime. 2007 world drug report (2007), United Nations Office for Drug Control and Crime Prevention, Vienna
56. United Nations Office on Drugs and Crime. 2008 world drug report (2008), United Nations Office on Drugs and Crime, Vienna
57. United States General Accounting Office. Drug control: DEA could improve its heroin signature and domestic monitor programs' geographic source data (2002), United States General Accounting Office report to the Co-Chairman, Caucus on International Narcotics Control, U.S. Senate, Washington, DC
58. US Department of Justice: National Drug Intelligence Center. Interagency domestic heroin threat assessment (2000), National Drug Intelligence Center, Johnstown, PA
59. US Department of Justice: National Drug Intelligence Center. The availability of southwest Asian heroin in the United States: A market analysis (2007), National Drug Intelligence Center, Johnstown, PA
60. US Drug Enforcement Administration. Special report: Black tar heroin in the United States (1986), Office of Intelligence, Drug Enforcement Administration, Washington, DC
61. US Drug Enforcement Administration. Drug intelligence report: US drug threat assessment: Availability, price, purity, use, and trafficking of drugs in the United States (1993), Drug Enforcement Administration, Washington, DC
62. US Drug Enforcement Administration. Domestic monitor program: 1993 annual summary (1994), Domestic Unit, Strategic Intelligence Section, Drug Enforcement Administration, Washington, DC
63. US Drug Enforcement Administration (June 21, 1995). News Release. Colombian heroin a major threat. almost one third of heroin seized in the United States Originates in South America. Retrieved July 31, 2007, from http://web.archive.org/web/20030427085041/www.usdoj.gov/dea/pubs/pressre l/pr950621.htm.
64. US Drug Enforcement Administration. The Availability of Southwest Asian Heroin in The United States (1996), Domestic Unit of the Strategic Intelligence Section, Drug Enforcement Administration, Washington, DC
65. US Drug Enforcement Administration. The South American cocaine trade: An "Industry" in transition (1996), Drug Enforcement Administration, Washington, DC
66. US Drug Enforcement Administration (1998). DEA Major Information Systems. Retrieved December 14, 2007, from http://www.dea.gov/foia/stride.html.
67. US Drug Enforcement Administration (2000). DEA briefing book. Retrieved September 10, 2007, from http://web.archive.org/web/20010124073400/www.dea.gov/briefingbook/index .html.
68. US Drug Enforcement Administration. The Mexican heroin trade (2000), Drug Enforcement Administration, Washington, DC
69. US Drug Enforcement Administration. Drug intelligence brief, drug intelligence trend: Increase in Mexican couriers transporting Colombian heroin to Mexico (2002), US Drug Enforcement Administration, Washington, DC
70. US Drug Enforcement Administration. (2005a). Drug Enforcement Administration: A tradition of excellence 1973-2003. Washington, DC: US Department of Justice, Drug Enforcement Administration. Retrieved 2nd August 2008 from http://www.usdoj.gov/dea/pubs/history/index.html.
71. Drug Enforcement Administration U.S. Domestic monitor program: 2004 annual summary (2005), Domestic Unit, Strategic Intelligence Section, US Drug Enforcement Administration, Washington, DC
72. US Drug Enforcement Administration. Special intelligence brief: "Cheese" (2006), Office of Forensic Sciences, Drug Enforcement Administration, Washington, DC
73. Vargas R. The anti-drug policy, aerial spraying of illicit crops and their social, environmental and political impacts in Colombia. Journal of Drug Issues 32 (2002) 11-60
74. Wasley A., Miller J.T., and Finelli L. Surveillance for acute viral hepatitis-United States, 2005. MMWR Morbidity and Mortality Weekly Report Surveillance Summaries 56 SS-3 (2007)
75. Weatherburn D., Freeman J.C., and Makkai K.T. Supply control and harm reduction: Lessons from the Australian heroin 'drought'. Addiction 98 1 (2003) 83-91
76. Werner S.B., Passaro D., McGee J., Schechter R., and Vugia D.J. Wound botulism in California 1951-1998: Recent epidemic in heroin injectors. Clinical Infectious Diseases 31 4 (2000) 1018-1024